http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2020010673-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1676
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4825
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4816
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
filingDate 2019-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_016b6c17c69acd8a7bac099de60ec8b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a97eefb1159bf9d8025ceee9b0ca78c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_626e78a0aa1c1fddbcf7c29a9775d6d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23a082c2880e9632c8c93d84d32f2b22
publicationDate 2020-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2020010673-A
titleOfInvention APIXABAN FORMULATIONS.
abstract The pharmaceutical formulation of apixaban is provided. A use of the apixaban formulation in the treatment of a thromboembolic disorder is also provided.
priorityDate 2018-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419496136
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10182969

Total number of triples: 26.